Creditors call for Protein Sciences liquidation

Two weeks after Protein Sciences announced that it had begun producing the world's first swine flu vaccine, creditors of the company filed a petition for involuntary bankruptcy. The creditors claimed $11.7 million. Emergent BioSolutions struck a deal last May to buy Protein Sciences' assets for $28 million in cash and the assumption of a $20 million note. Report

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.